Search research articles

Related Concept Videos

Birth Control Methods

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Why it is timely to bring a new hormonal male contraceptive to the public - A 35-year perspective of the authors.

Andrology·2024

Same author

Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines.

Andrology·2023

Same author

Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).

Contraception·2023

Same author

Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototype.

Contraception·2020

Same author

Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.

The Journal of clinical endocrinology and metabolism·2020

Same author

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

The Journal of clinical endocrinology and metabolism·2018

Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026

Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026

Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026

Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026

Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Contraception for men: a breakthrough new approach.

William J Bremner¹

¹Department of Medicine, University of Washington, Seattle, WA 98195, USA. wbremner@uw.edu

|August 21, 2012

Summary

This summary is machine-generated.

A novel small molecule drug successfully and reversibly inhibits sperm production in male mice. This breakthrough offers a potential new male contraceptive by targeting testicular bromodomain function without side effects.

More Related Videos

Optimizing the Modified No-Scalpel Vasectomy Technique

Optimizing the Modified No-Scalpel Vasectomy Technique

Published on: October 18, 2024

High-Resolution Respirometry to Assess Mitochondrial Function in Human Spermatozoa

High-Resolution Respirometry to Assess Mitochondrial Function in Human Spermatozoa

Published on: June 23, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Optimizing the Modified No-Scalpel Vasectomy Technique

Optimizing the Modified No-Scalpel Vasectomy Technique

Published on: October 18, 2024

High-Resolution Respirometry to Assess Mitochondrial Function in Human Spermatozoa

High-Resolution Respirometry to Assess Mitochondrial Function in Human Spermatozoa

Published on: June 23, 2023

Area of Science:

Reproductive biology
Molecular pharmacology
Male contraception

Background:

The development of male contraceptives has lagged significantly, with condoms being the only reversible option for centuries.
Existing research highlights the need for innovative approaches beyond traditional methods.

Discussion:

This study introduces a targeted molecular strategy for male contraception.
The research focuses on the direct and reversible inhibition of spermatogenesis.

Key Insights:

A specific small molecule was administered to mice, effectively blocking testicular bromodomain function.
This inhibition led to a reversible suppression of sperm production.
Crucially, no adverse effects were observed in the male mice or their offspring.

Outlook:

This research paves the way for the development of new non-hormonal male contraceptive agents.
Further investigation into the long-term efficacy and safety in preclinical models is warranted.
The identified molecular target could be a promising avenue for future male reproductive health interventions.